Pioneering the Future of Life Sciences

We have released “FLD HbA1c” on our app store, “SFM App Store,” since the end of September 2025. With increasing attention from overseas, we have significantly revamped our website on December 2, 2025, to enable global accessibility. In 2026, we aim to further contribute to the world with presentations on LDL cholesterol at academic conferences, … Read more “Website Renewal”

For over ten years, our company has been developing technology for completely non-contact and non-invasive blood test information measurement, grounded in mathematical and neuroscientific principles. On August 29, 2025, we will present our technology at the Annual Meeting of the Japanese Association of Clinical Laboratory Medicine, and starting from the end of September 2025, we … Read more “The Android version of the LDL Cholesterol App has been completed.”

After extensive foundational research, SFM Corporation independently developed the Android app “FLD HbA1c,” which was launched in seven countries across Southeast and Southwest Asia on October 22, 2025. Subsequently, it was released in five countries within the Asia-Oceania region on November 3, 2025, and in four countries within the Asia-Central America region on November 16, … Read more “We have increased the number of foreign countries where FLD HbA1c is available.”